Related Experiment Videos
[Extrapulmonary infections due to Mycoplasma pneumoniae]
J-M Garnier1, G Noël, K Retornaz
1Hôpital nord de Marseille, assistance publique-hôpitaux de Marseille, chemin des Bourrely, 13915 Marseille cedex 20, France. jean-marc.garnier@mail.ap-hm.fr
Summary
Mycoplasma pneumoniae causes pneumonia in children, but can also lead to unusual extrapulmonary symptoms like neurological, cardiac, and skin issues. These complications may arise from direct invasion or autoimmune responses.
Area of Science:
- Pediatric Infectious Diseases
- Microbiology
- Clinical Medicine
Context:
- Mycoplasma pneumoniae is a common respiratory pathogen in children, typically causing pneumonia.
- However, extrapulmonary manifestations of M. pneumoniae infections are increasingly recognized.
- Understanding these diverse clinical presentations is crucial for accurate diagnosis and management.
Purpose:
- To review and describe the unusual clinical features of Mycoplasma pneumoniae infections in children beyond typical pneumonia.
- To highlight the range of extrapulmonary manifestations, including neurological, cardiac, hematologic, and other organ systems.
- To discuss the potential pathogeny and controversial treatment aspects of these complications.
Summary:
- Mycoplasma pneumoniae infections in children can present with a wide spectrum of extrapulmonary symptoms.
- Neurological complications such as encephalitis and meningoencephalitis are most common, followed by meningitis, myelitis, and polyradiculitis.
- Cardiac involvement (pericarditis, myocarditis), cold agglutinin hemolytic anemia, and skin, renal, gastrointestinal, and osteoarticular manifestations have also been reported.
- The exact mechanisms, including direct invasion and autoimmune responses, are not fully understood, and treatment strategies remain debated.
Impact:
- This review enhances clinical awareness of the diverse manifestations of Mycoplasma pneumoniae in pediatric patients.
- It aids clinicians in recognizing and diagnosing less common complications, potentially improving patient outcomes.
- Further research into the pathogeny and optimal treatment of extrapulmonary M. pneumoniae infections is warranted.